Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 24577093)

1.

MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2.

Ruan Q, Wang P, Wang T, Qi J, Wei M, Wang S, Fan T, Johnson D, Wan X, Shi W, Sun H, Chen YH.

Cell Death Dis. 2014 Feb 27;5:e1095. doi: 10.1038/cddis.2014.47.

2.

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.

Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH.

Cell. 2008 May 2;133(3):415-26. doi: 10.1016/j.cell.2008.03.026.

3.

Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.

Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y, Sheng ZY.

Mol Immunol. 2011 Oct;49(1-2):219-26. doi: 10.1016/j.molimm.2011.08.016. Epub 2011 Oct 2.

PMID:
21963221
4.

Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein.

Lou Y, Liu S, Zhang C, Zhang G, Li J, Ni M, An G, Dong M, Liu X, Zhu F, Zhang W, Gao F, Chen YH, Zhang Y.

J Immunol. 2013 Nov 1;191(9):4849-57. doi: 10.4049/jimmunol.1300053. Epub 2013 Sep 30.

5.

MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.

Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM.

Mol Cancer. 2014 Feb 24;13:35. doi: 10.1186/1476-4598-13-35.

6.

TIPE2 protein negatively regulates HBV-specific CD8⁺ T lymphocyte functions in humans.

Zhang W, Zhang J, Zhao L, Shao J, Cui J, Guo C, Zhu F, Chen YH, Liu S.

Mol Immunol. 2015 Mar;64(1):204-9. doi: 10.1016/j.molimm.2014.11.019. Epub 2014 Dec 12.

PMID:
25499447
7.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
8.

TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway.

Sun H, Zhuang G, Chai L, Wang Z, Johnson D, Ma Y, Chen YH.

J Immunol. 2012 Sep 15;189(6):2768-73. doi: 10.4049/jimmunol.1103477. Epub 2012 Aug 17.

9.

MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis.

Meisgen F, Xu N, Wei T, Janson PC, Obad S, Broom O, Nagy N, Kauppinen S, Kemény L, Ståhle M, Pivarcsi A, Sonkoly E.

Exp Dermatol. 2012 Apr;21(4):312-4. doi: 10.1111/j.1600-0625.2012.01462.x.

PMID:
22417311
10.

Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten.

Jindra PT, Bagley J, Godwin JG, Iacomini J.

J Immunol. 2010 Jul 15;185(2):990-7. doi: 10.4049/jimmunol.1000793. Epub 2010 Jun 14.

11.

Tissue-specific expression of TIPE2 provides insights into its function.

Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y, Qu Z, Guo C, Chen Y, Zhang Y, Liu S.

Mol Immunol. 2010 Sep;47(15):2435-42. doi: 10.1016/j.molimm.2010.06.016. Epub 2010 Jul 21.

PMID:
20663561
12.

The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.

Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S, Zhang L, Chen YH.

Mol Cell. 2012 Mar 9;45(5):610-8. doi: 10.1016/j.molcel.2012.01.006. Epub 2012 Feb 8.

13.

Regulation of T lymphocyte activation by microRNA-21.

Wang L, He L, Zhang R, Liu X, Ren Y, Liu Z, Zhang X, Cheng W, Hua ZC.

Mol Immunol. 2014 Jun;59(2):163-71. doi: 10.1016/j.molimm.2014.02.004. Epub 2014 Mar 13.

PMID:
24631982
14.

MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20).

Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):7865-70. doi: 10.1073/pnas.1200081109. Epub 2012 May 1.

15.

MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages.

Jiang P, Liu R, Zheng Y, Liu X, Chang L, Xiong S, Chu Y.

Exp Cell Res. 2012 Jun 10;318(10):1175-84. doi: 10.1016/j.yexcr.2012.03.018. Epub 2012 Mar 27.

PMID:
22483937
16.

MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation.

Rusca N, Dehò L, Montagner S, Zielinski CE, Sica A, Sallusto F, Monticelli S.

Mol Cell Biol. 2012 Nov;32(21):4432-44. doi: 10.1128/MCB.00824-12. Epub 2012 Aug 27.

17.

TIPE2, a novel regulator of immunity, protects against experimental stroke.

Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, Fan B, Yang F, Huang S, Jiang F, Chen YH, Yi F.

J Biol Chem. 2012 Sep 21;287(39):32546-55. Epub 2012 Aug 2.

18.

miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation.

Xue F, Li H, Zhang J, Lu J, Xia Y, Xia Q.

Genes Immun. 2013 Mar;14(2):127-31. doi: 10.1038/gene.2012.58. Epub 2013 Jan 10.

PMID:
23303246
19.

Critical roles of TIPE2 protein in murine experimental colitis.

Lou Y, Sun H, Morrissey S, Porturas T, Liu S, Hua X, Chen YH.

J Immunol. 2014 Aug 1;193(3):1064-70. doi: 10.4049/jimmunol.1400415. Epub 2014 Jun 27.

20.

NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.

Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, di Gaudio F, Turco MC, Petrella A, de Maria R, Stassi G.

Arthritis Rheum. 2005 Jul;52(7):2179-91.

PMID:
15986355
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk